These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30085132)

  • 1. miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas.
    Peng KY; Chang HM; Lin YF; Chan CK; Chang CH; Chueh SJ; Yang SY; Huang KH; Lin YH; Wu VC; Wu KD
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3737-3747. PubMed ID: 30085132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic Reticulum Chaperone Calmegin Is Upregulated in Aldosterone-Producing Adenoma and Associates With Aldosterone Production.
    Itcho K; Oki K; Gomez-Sanchez CE; Gomez-Sanchez EP; Ohno H; Kobuke K; Nagano G; Yoshii Y; Baba R; Hattori N; Yoneda M
    Hypertension; 2020 Feb; 75(2):492-499. PubMed ID: 31865789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.
    Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J
    Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.
    Guo Z; Nanba K; Udager A; McWhinney BC; Ungerer JPJ; Wolley M; Thuzar M; Gordon RD; Rainey WE; Stowasser M
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3224-35. PubMed ID: 32516371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YPEL4 modulates HAC15 adrenal cell proliferation and is associated with tumor diameter.
    Oki K; Plonczynski MW; Gomez-Sanchez EP; Gomez-Sanchez CE
    Mol Cell Endocrinol; 2016 Oct; 434():93-8. PubMed ID: 27333825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
    Vanderriele PE; Caroccia B; Seccia TM; Piazza M; Lenzini L; Torresan F; Iacobone M; Unger T; Rossi GP
    Clin Sci (Lond); 2018 Mar; 132(6):627-640. PubMed ID: 29436482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
    Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
    Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas.
    Duparc C; Moreau L; Dzib JF; Boyer HG; Tetsi Nomigni M; Boutelet I; Boulkroun S; Mukai K; Benecke AG; Amar L; Gobet F; Meatchi T; Plouin PF; Zennaro MC; Louiset E; Lefebvre H
    J Clin Endocrinol Metab; 2015 Apr; 100(4):E550-60. PubMed ID: 25599386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-375 in aldosterone-producing adenomas promotes tumour cell growth via MTDH.
    He J; Cao Y; Su T; Jiang Y; Jiang L; Zhou W; Zhang C; Wang W; Ning G
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):581-9. PubMed ID: 25944465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism.
    Lenzini L; Caroccia B; Campos AG; Fassina A; Belloni AS; Seccia TM; Kuppusamy M; Ferraro S; Skander G; Bader M; Rainey WE; Rossi GP
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E674-82. PubMed ID: 24285684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
    Choi M; Scholl UI; Yue P; Björklund P; Zhao B; Nelson-Williams C; Ji W; Cho Y; Patel A; Men CJ; Lolis E; Wisgerhof MV; Geller DS; Mane S; Hellman P; Westin G; Åkerström G; Wang W; Carling T; Lifton RP
    Science; 2011 Feb; 331(6018):768-72. PubMed ID: 21311022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purkinje Cell Protein 4 Expression Is Associated With DNA Methylation Status in Aldosterone-Producing Adenoma.
    Kobuke K; Oki K; Gomez-Sanchez CE; Ohno H; Itcho K; Yoshii Y; Yoneda M; Hattori N
    J Clin Endocrinol Metab; 2018 Mar; 103(3):965-971. PubMed ID: 29294065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
    Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
    Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.
    Li X; Wang B; Tang L; Zhang Y; Chen L; Gu L; Zhang F; Ouyang J; Zhang X
    J Clin Endocrinol Metab; 2018 Mar; 103(3):813-823. PubMed ID: 29165597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Different Calcium Channel Blockers on Aldosterone-Producing Adenoma Cells.
    Wang F; Ma X; Tong A; Zhang Y; Wen J; Li Y
    Front Endocrinol (Lausanne); 2020; 11():260. PubMed ID: 32411097
    [No Abstract]   [Full Text] [Related]  

  • 16. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
    Gao X; Yamazaki Y; Tezuka Y; Onodera Y; Ogata H; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105434. PubMed ID: 31351131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.
    Berthon A; Drelon C; Ragazzon B; Boulkroun S; Tissier F; Amar L; Samson-Couterie B; Zennaro MC; Plouin PF; Skah S; Plateroti M; Lefèbvre H; Sahut-Barnola I; Batisse-Lignier M; Assié G; Lefrançois-Martinez AM; Bertherat J; Martinez A; Val P
    Hum Mol Genet; 2014 Feb; 23(4):889-905. PubMed ID: 24087794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
    Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
    Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calneuron 1 Increased Ca
    Kobuke K; Oki K; Gomez-Sanchez CE; Gomez-Sanchez EP; Ohno H; Itcho K; Yoshii Y; Yoneda M; Hattori N
    Hypertension; 2018 Jan; 71(1):125-133. PubMed ID: 29109191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.